Patent ID: 8679512

Claim:
A method for the treatment of a dermatological disease, comprising topically administering an effective amount of a propellant-free pharmaceutical formulation as a spray to a subject in need thereof, wherein said formulation consists of: micronized particles of beclometasone dipropionate (BDP) suspended in an aqueous phase, said aqueous phase comprising: an emulsifying agent selected from the class of polysorbates in an amount of 0.1 to 0.2% w/v, based on the total volume of the formulation; a sugar or a sugar alcohol in an amount of 5.0 to 5.2% w/v, based on the total volume of the formulation; a mixture of microcrystalline cellulose and carboxymethylcellulose sodium in an amount of 0.5 to 1.0% w/v, based on the total volume of the formulation; one or more preservatives; and water up to 100%, wherein said dermatological disease is atopic dermatitis, acne, or psoriasis, and wherein said formulation is administered in such an amount that said beclometasone dipropionate is administered in an amount of 25 to 100 μg.